Treatment of aspergillosis & aspergilloma

There are dozens of different types of aspergillosis effecting many organs of the body. This section provides detailed protocols on the treatment of those infections and details of their most prominant references.

There are also details of all the antifungal drugs currently in use and of new antifungals emerging for the treatment of Aspergillosis.

If you are a patient we have information written specifically for you on these subjects in the Aspergillosis for Patients website .

National Aspergillosis Centre
This is a UK - based centre funded by the NHS NAC

GUIDELINES: The European Medicines Agency has published draft guidelines on the "Clinical Evaluation of Antifungal agents for The Treatment and Prophylaxis of Invasive Fungal Disease" comments before November 30th 2009, are invited at the following address EWPSecretariat@emea.europa.eu

Invasive Aspergillosis

Therapeutic issues in particular patient groups:

	Allogeneic bone marrow transplantation
	Aspergillosis in AIDS
	Burns and Aspergillosis
	Chronic granulomatous disease
	Heart transplantation
	Kidney transplantation
	Liver transplantation
	Lung transplantation
	Neonatal aspergillosis
	Neutropenia
	Non or mildly immunocompromised patient
	Pediatric aspergillosis
	Post-operative aspergillosis

Invasive pulmonary aspergillosis

Invasive pulmonary aspergillosis

Treatment of particular organs:

	Acute invasive Aspergillus sinusitis
	Airways (tracheobronchial)
	Aspergillus empyema
	Aspergillus endocarditis
	Aspergillus pericarditis - updated June 2009
	Aspergillus thyroiditis
	Bronchial stump aspergillosis
	Central nervous system
		Meningitis
		Parenchymal infection (abscess/infarction)
	Epiglottis and laryngeal aspergillosis
	Gastric and colonic aspergillosis
	Invasive external otitis
	Oesophageal aspergillosis
	Oral aspergillosis
	Osteomyelitis
	Peritonitis in the context of CAPD
	Renal aspergillosis
	Vascular graft infection with Aspergillus

Chronic Aspergillosis

Chronic pulmonary aspergillosis

Chronic pulmonary aspergillosis - updated February 2009

Chronic Aspergillus sinusitis

Chronic Aspergillus sinusitis - Updated March 2008

Aspergilloma

Aspergilloma

Allergic Aspergillus diseases

APBA

APBA

Allergic Fungal Rhinosinusitis (AFRS)

Allergic Fungal Rhinosinusitis (AFRS)

Other noninvasive Aspergillus diseases

Saprophytic sinusitis

Saprophytic sinusitis

Otomycosis

Otomycosis

Keratitis

Keratitis

Onychomycosis

Onychomycosis

Antifungal drug Summaries of Product Characteristics (SPC)

USA

	Amphotericin B (Amphocin)
	Amphotericin B colloidal dispersion (Amphotec)
	Amphotericin B lipid complex (Abelcet)
	Anidulafungin (Eraxis)
	Caspofungin acetate (Cancidas)
	Itraconazole (USA)(Sporanox)
		Interaction with corticosteroids
		Itraconazole (SPORANOX) - capsules
		Itraconazole (SPORANOX) IV
		Itraconazole (SPORANOX) oral solution
	Liposomal amphotericin B (Ambisome)
	Micafungin (Mycamine)
	Posaconazole (Noxafil)
	Voriconazole (V-fend)

	Amphotericin B (Fungizone)
	Amphotericin B colloidal dispersion (Amphocil)
	Amphotericin B lipid complex (Abelcet)
	Caspofungin acetate (Cancidas)
	Flucytosine (Ancotil)
	Itraconazole (UK)(Sporanox)
		Capsules
		Interaction with corticosteroids
		Itraconazole (Liquid)
		Itraconazole (Pulse)
		IV
	Liposomal amphotericin B (AmBisome)
	Micafungin (Mycamine)
	Posaconazole (Noxafil)
	Voriconazole (v-Fend)